Alabama - Page 193 of 277

Antibiograms and Infection Prevention Efforts to Combat Antimicrobial Resistance Post COVID-19

by Maya Labat | Apr 27, 2021

Antimicrobial resistance may have increased during COVID-19 pandemic due to the medications being used to treat the virus including steroids and other immune-suppressive medications, longer hospital length of stay, ICU length of stay, and duration of mechanical...

Powerful Partnerships – Area Offices on Aging & Community Coalitions

by Maya Labat | Apr 27, 2021

In recognition of Older Americans Month, please join our conversation with community coalition colleagues to learn how to create Communities of Strength by partnering with your Area Office on Aging (AAA).

A Deeper Dive into Diabetic Agent and Anticoagulation Medication Adverse Drug Events

by Maya Labat | Apr 27, 2021

This LAN will take you through the most common ADEs and their risk factors for anticoagulant and diabetes medications. Case studies will be discussed to help hone your skills for identifying ADEs.

Antipsychotic Adverse Drug Events (ADEs) One-Pager

by Maya Labat | Apr 22, 2021

This resource provides information on adverse drug events for antipsychotic medications.

A Guide for Community Partners

by Maya Labat | Apr 20, 2021

CDC has developed a community guide to to increase vaccine uptake in racial and ethnic minority communities.

Antibiograms and Infection Prevention Efforts to Combat Antimicrobial Resistance Post COVID-19

Powerful Partnerships – Area Offices on Aging & Community Coalitions

A Deeper Dive into Diabetic Agent and Anticoagulation Medication Adverse Drug Events

Antipsychotic Adverse Drug Events (ADEs) One-Pager

A Guide for Community Partners

Contact

Company Info